Delivery Order SPE2DB22D1017-SPE2DB25FG3RM
Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $5.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for XELJANZ XR 11 mg tablets in 30-count unit doses, valued at $18,565.52 under a firm fixed price contract type. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,776.31 by the Defense Logistics Agency for XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a ceiling value of approximately $55.1K and an ultimate completion date of September 5, 2025. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,644.21 by the Defense Logistics Agency (DLA) for the supply of Xeljanz 10 mg tablets in quantities of 60 units. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price, non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,552.30 firm fixed-price delivery order is for XELJANZ 5 MG TABLET and has an ultimate completion date of October 6, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 3, 2025, for XELJANZ XR 11 mg tablets in 30-count units, with a ceiling value of $10,286.16. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for $17,709.48 under a firm fixed price contract type. The award covers the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, a prescription medication used to treat inflammatory conditions. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,239.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $5,121.37 order has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,873.07 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 8, 2025, for XELJANZ XR 11 mg tablets (30-count packages). The award, which carries an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...